Literature DB >> 30059896

Establishing the diagnosis of multiple sclerosis in Croatian patients with clinically isolated syndrome: 2010 versus 2017 McDonald criteria.

Mario Habek1, Tin Pavičić2, Berislav Ruška2, Ivan Pavlović2, Tereza Gabelić3, Barbara Barun3, Ivan Adamec4, Luka Crnošija4, Magdalena Krbot Skorić5.   

Abstract

AIM: To compare the sensitivity, specificity and accuracy of the 2010 and 2017 revisions of the McDonald criteria in a Croatian cohort of patients with a clinically isolated syndrome (CIS).
METHODS: Prospectively collected data from 113 patients were retrospectively analyzed. Sensitivity, specificity and accuracy for both criteria were calculated regarding conversion to clinically definite multiple sclerosis (Poser CDMS) or multiple sclerosis (MS) (defined as fulfilment of clinical or MRI evidence for dissemination in space and the development of a second relapse and/or ≥1 new T2 lesions on the follow-up MRIs) during a two-year follow-up. Survival analysis was performed to estimate the cumulative risk of patients developing Poser CDMS. Binary logistic regression model was used to determine which variables are statistically significant predictors for the conversion to MS.
RESULTS: The 2017 revision had higher sensitivity (85 vs. 30% and 85 vs. 41%) and lower specificity (33 vs. 63% and 63 vs. 85%) compared to the 2010 revisions, for conversion to Poser CDMS and MS, respectively. Patients who did not meet the 2017 McDonald criteria had a higher chance of conversion-free survival for Poser CDMS than those who met the 2017 McDonald criteria (p = 0.037). Results of the multivariate regression analysis revealed that patients who at baseline fulfilled 2017 revisions of the McDonald criteria have the increased likelihood of conversion to MS (Exp(B) 9.68, 95%CI 3.62-25.90, p < 0.00001).
CONCLUSION: This study provides new information about the application of the 2017 revisions of the McDonald criteria in a Croatian cohort of patients with typical CIS.
Copyright © 2018. Published by Elsevier B.V.

Entities:  

Keywords:  CSF-specific oligoclonal IgG bands; Dissemination in space; Dissemination in time; McDonald criteria; Multiple sclerosis; Symptomatic lesions

Mesh:

Substances:

Year:  2018        PMID: 30059896     DOI: 10.1016/j.msard.2018.07.035

Source DB:  PubMed          Journal:  Mult Scler Relat Disord        ISSN: 2211-0348            Impact factor:   4.339


  5 in total

1.  Effects of fingolimod treatments on alanine transaminase and aspartate transaminase levels in patients with multiple sclerosis.

Authors:  Saeid Sadeghi Joni; Masoumeh Cheshmavar; Pouria Shoureshi; Zohreh Zamani; Niusha Taoosi; Morteza Akbari; Mahdieh Afzali
Journal:  Int J Physiol Pathophysiol Pharmacol       Date:  2020-06-15

2.  Application of the 2017 McDonald criteria in a Chinese population with clinically isolated syndrome.

Authors:  Yang Zheng; Chun-Hong Shen; Sa Wang; Fan Yang; Meng-Ting Cai; Wei Fang; Yin-Xi Zhang; Mei-Ping Ding
Journal:  Ther Adv Neurol Disord       Date:  2020-01-20       Impact factor: 6.570

3.  Integrative biochemical, proteomics and metabolomics cerebrospinal fluid biomarkers predict clinical conversion to multiple sclerosis.

Authors:  Fay Probert; Tianrong Yeo; Yifan Zhou; Megan Sealey; Siddharth Arora; Jacqueline Palace; Timothy D W Claridge; Rainer Hillenbrand; Johanna Oechtering; David Leppert; Jens Kuhle; Daniel C Anthony
Journal:  Brain Commun       Date:  2021-04-19

Review 4.  Treatment of relapsing multiple sclerosis - recommendations of the Croatian Neurological Society.

Authors:  Mario Habek; Ivan Adamec; Barbara Barun; Vanja Bašić Kes; Andrijana Bogoje Raspopović; Klaudia Duka Glavor; Tereza Gabelić; Tihana Grzinčić; Mirjam Jukić; Miljenka-Jelena Jurašić; Spomenka Kiđemet-Piskač; Milica Komšo; Julija Rimac; Ines Lazibat; Branka Lukić; Anita Marčinko; Meri Matijaca; Marija Ratković; Lidija Šapina; Vladimira Vuletić; Tea Mirošević Zubonja; Magdalena Krbot Skorić
Journal:  Croat Med J       Date:  2022-08-31       Impact factor: 2.415

5.  Correlation of Dietary Intake and Helicobacter pylori Infection with Multiple Sclerosis, a Case-Control Study in Rafsanjan, Iran, 2017-18.

Authors:  Sara Kiani; Alireza Vakilian; Zahra Kamiab; Ali Shamsizadeh
Journal:  Qatar Med J       Date:  2021-02-05
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.